fda warning letter bpc-157 dietary supplement Sends Letters to More Than 50 GLP-1 Compounders and Manufacturers bpc-157 fda warning letter compounding

Disclosure: Some study authors declared affiliations with biotech, pharmaceutical, and/or device companies

Understanding peptide testing results enables independent verification of vendor quality claims

Although diabetes incidence showed only a modest increase in all mice, the study found a significant acceleration of T1D onset in females and an increase in insulitis in males (114)

The Defense Departments own Operation Supplement safety site warns service members to stay clear of products containing BPC-157, which are sold online as research chemicals and carry statements such as Not for human consumption, Research use only, or For research purposes only. The marketed benefits of BPC-157 have only been shown in lab or animal studies (rats, mice, and dogs), the DoD supplement site states